Geneoscopy to Participate in Upcoming Investor Conferences
Morgan Stanley Global Healthcare Conference in New York City
September 8, 2025 - September 10, 2025
Bank of America Healthcare Trailblazers Private Company Conference in Boston
September 17, 2025 - September 18, 2025
UBS Global Healthcare Conference in Palm Beach Gardens
November 9, 2025 - November 12, 2025
Stifel Healthcare Conference in New York City
November 11, 2025 - November 13, 2025
One-on-one meetings with company management are available during the conferences upon request.
About Geneoscopy, Inc.
Geneoscopy, Inc. is a life sciences company focused on developing diagnostic tests for gastrointestinal health. Leveraging its proprietary, patented stool-derived eukaryotic RNA (seRNA) biomarker platform, Geneoscopy's mission is to empower patients and providers to transform gastrointestinal health through innovative diagnostics. The company's FDA-approved ColoSense test uses a proprietary RNA-based platform to screen for colorectal cancer and advanced adenomas for average-risk individuals over the age of 45. In partnership with leading universities and biopharmaceutical companies, Geneoscopy is also developing diagnostic tests for treatment selection and therapy monitoring in other areas of gastrointestinal health. For more information, visit www.geneoscopy.com and follow the company on LinkedIn.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
20 minutes ago
- Business Wire
Susan G. Komen ® To Host 2025 Northeast Ohio MORE THAN PINK Walk This September
CLEVELAND--(BUSINESS WIRE)-- Susan G. Komen ®, the world's leading breast cancer organization, will convene breast cancer survivors, those living with metastatic breast cancer (MBC) and supporters at the 2025 Susan G. Komen Northeast Ohio MORE THAN PINK Walk. This impactful event unites our community and raises money for the mission of Komen, supporting those affected by breast cancer. Komen aims to raise over $350,000 at the Northeast Ohio MORE THAN PINK Walk, generating critical funds that allow Komen to continue its investment in lifesaving work across the country, including promising research that will allow people to live longer lives with better outcomes. This event also funds Komen's Patient Care Center, a trusted, go-to source for timely, accurate breast health and breast cancer information, support and resources, as well as the work of Komen's Center for Public Policy to drive state and federal policies that invest in critical programs and ensure streamlined access to affordable, high-quality breast health care. WHEN: Saturday, September 20, 2025 WHERE: Wade Oval - 10820 East Blvd, Cleveland, OH 44106 WHY IT MATTERS: Breast cancer affects 1 in 8 women in the U.S. and 1 in 1,000 men in their lifetime. In 2025 alone, an estimated 316,950 women in the U.S. will be diagnosed with breast cancer and 42,170 women will die from the disease. Approximately 2,800 men will be diagnosed with breast cancer and 510 will die from it. However, some experts say one-third of breast cancer deaths in the U.S. could be prevented with universal access to modern treatments. In Ohio, approximately over 77,000 people will be diagnosed with breast cancer and over 24,000 will die from the disease this year. Susan G. Komen provides direct support to Ohioans through its Patient Care Center. In fiscal year 2025, Komen provided assistance to over 1,300 patients, including over $358,000 in financial assistance to eligible people in active treatment or living with metastatic breast cancer. 'The work Komen does for people with breast cancer, survivors and those with increased risk of breast cancer is not possible without the Northeast Ohio MORE THAN PINK Walk and the critical money we raise from our generous supporters,' said Sean Shacklett, executive director Ohio & Michigan at Susan G. Komen. 'We look forward to bringing together the Northeast Ohio community this fall and uniting around our goal of creating a world where we do not lose another life to this disease.' Bank of America is the national presenting sponsor and Lilly, Natera, and Novartis are national series sponsors for the MORE THAN PINK Walk and Race for the Cure events. About Susan G. Komen ® Susan G. Komen ® is the world's leading nonprofit breast cancer organization, working to save lives and end breast cancer forever. Komen has an unmatched, comprehensive 360-degree approach to fighting this disease across all fronts and supporting millions of people in the U.S. and in countries worldwide. We advocate for patients, drive research breakthroughs, improve access to high-quality care, offer direct patient support and empower people with trustworthy information. Founded by Nancy G. Brinker, who promised her sister, Susan G. Komen, that she would end the disease that claimed Suzy's life, Komen remains committed to supporting those affected by breast cancer today, while tirelessly searching for tomorrow's cures. Visit or call 1-877 GO KOMEN. Connect with us on social at
Yahoo
43 minutes ago
- Yahoo
Palo Alto Networks Q4 Earnings and Revenues Surpass Estimates
Palo Alto Networks PANW delivered fourth-quarter fiscal 2025 non-GAAP earnings of 95 cents per share, which beat the Zacks Consensus Estimate by 7.9%. The figure improved 27% year over Alto Networks' earnings beat the Zacks Consensus Estimate in each of the trailing four quarters, with an average surprise of 5%.Palo Alto Networks' fourth-quarter fiscal 2025 revenues of $2.54 billion surpassed the Zacks Consensus Estimate by 1.6%. This compares to year-ago revenues of $2.19 by better-than-expected results, shares of Palo Alto Networks were up 5.92% in the after-market hours. Palo Alto Networks' strong performance in the fourth quarter of fiscal 2025 can be attributed to a robust year-over-year rise in its Subscription & Support revenues, alongside a solid gain in Product revenues. Shares of Palo Alto Networks have gained 1.4%, underperforming the Zacks Security industry's return of 7.2% year to date. Palo Alto Networks, Inc. Price, Consensus and EPS Surprise Palo Alto Networks, Inc. price-consensus-eps-surprise-chart | Palo Alto Networks, Inc. Quote Palo Alto Networks' Q4 2025 Details Product revenues rose 19.4% year over year to $573.9 million, accounting for 22.6% of total revenues. Subscription and Support revenues, which represented 77.4% of total revenues, grew 14.8% to $1.96 billion, driven by continued momentum across Prisma and Cortex revenues at the end of the fiscal fourth quarter were $6.30 billion. Remaining performance obligation climbed to $15.8 billion, up 24% year over year. Meanwhile, Next-Generation Security annualized recurring revenues hit $5.58 billion, representing a 32% year-over-year increase and a 9.6% sequential gross profit rose to $1.92 billion, up 14.3% year over year, while the non-GAAP gross margin contracted 100 basis points to 75.8%. Non-GAAP operating income increased 30.6% to $768.2 million, and the non-GAAP operating margin improved 340 basis points to 30.3% compared to the year-ago period. PANW's Balance Sheet & Cash Flow As of July 31, 2025, Palo Alto Networks had $2.9 billion in cash, cash equivalents, and short-term investments, down from $3.3 billion as of April 30, company generated $1.02 billion in operating cash flow and reported a non-GAAP adjusted free cash flow of $ 954.5 million in the fourth quarter of fiscal 2025. Palo Alto Networks Initiates FY26 Guidance For fiscal 2026, Palo Alto Networks expects revenues between $10.48 billion and $10.53 billion. The Zacks Consensus Estimate for fiscal 2025 revenues is pegged at $10.43 billion, indicating a rise of 13.6%. Remaining Performance Obligation is projected in the range of $18.6-$18.7 billion. Next-Gen Security ARR is estimated in the band of $7.00-$7.10 Alto Networks' fiscal 2025 non-GAAP operating margin is projected in the range of 29.2- 29.7%. Its adjusted free cash flow margin is estimated in the range of 38-39%. The company expects non-GAAP earnings per share in the range of $3.75-$3.85. After a two-for-one stock split of PANW shares on Nov. 20, 2024, the outstanding share count is in the band of 710-716 million. The consensus mark for fiscal 2025 earnings is pinned at $3.65 per share, suggesting an improvement of 11.4%. The figure has been revised upward by a penny over the past 30 the first quarter of fiscal 2026, Palo Alto Networks projects revenues between $2.45 billion and $2.47 billion, which suggests year-over-year growth of 14-15%. The Zacks Consensus Estimate for fourth-quarter fiscal 2025 revenues is pegged at $2.44 billion, indicating a rise of 13.9%. Remaining Performance Obligations are anticipated between $15.4 billion and $15.5 billion. Next-Gen Security ARR is expected in the band of $5.82-$5.84 earnings are projected in the range of 88-90 cents per share. The Zacks Consensus Estimate for non-GAAP earnings is pegged at 84 cents per share, which has been revised upward by a penny over the past 30 days, indicating a year-over-year improvement of 7.7%. Zacks Rank and Stocks to Consider Currently, Palo Alto Networks carries a Zacks Rank #4 (Sell).Amphenol APH, Qualys QLYS and F5 FFIV are some better-ranked stocks that investors can consider in the broader Zacks Computer & Technology sector. Amphenol, Qualys and F5 sport a Zacks Rank #1 (Strong Buy) each at present. You can see the complete list of today's Zacks #1 Rank stocks shares have gained 59.9%, year to date. The Zacks Consensus Estimate for Amphenol's full-year 2025 earnings is pegged at $3.02 per share, up by 4 cents over the past seven days, suggesting a growth of 59.8% from the year-ago quarter's reported shares have declined 6.9%, year to date. The Zacks Consensus Estimate for Qualys's full-year fiscal 2025 earnings has been revised upward to $6.35 in the past 30 days, suggesting year-over-year growth of 3.6%.F5 shares have gained 25.7%, year to date. The Zacks Consensus Estimate for F5's full-year 2025 earnings is pegged at $15.38 per share, implying a rise of 15% from the year-ago quarter's levels. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Amphenol Corporation (APH) : Free Stock Analysis Report F5, Inc. (FFIV) : Free Stock Analysis Report Palo Alto Networks, Inc. (PANW) : Free Stock Analysis Report Qualys, Inc. (QLYS) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
43 minutes ago
- Yahoo
FTNT vs. QLYS: Which Cybersecurity Stock Deserves Your Investment?
In the rapidly evolving cybersecurity landscape, Fortinet FTNT and Qualys QLYS stand out as prominent players addressing critical security needs for organizations worldwide. Both companies have established themselves as leaders in their respective niches — Fortinet with its comprehensive network security and firewall solutions, and Qualys with its cloud-based vulnerability management and compliance platform. As the global cybersecurity market prepares for explosive growth, projected to reach $351.9 billion by 2030 according to MarketsandMarkets report, investors are evaluating which security stocks offer the most compelling investment cyber threats escalating in sophistication and frequency, organizations are increasing their security budgets by 15% in 2025, as reported by Gartner. Both companies recently reported their second-quarter 2025 earnings, providing fresh insights into their strategic positioning and growth trajectories. While Fortinet continues to dominate the network security space with its FortiGate firewalls and expanding SASE offerings, Qualys is revolutionizing risk management through its innovative AI-powered Risk Operations Center and comprehensive vulnerability assessment delve deep and closely compare the fundamentals of the two stocks to determine which one is a better investment now. The Case for FTNT Fortinet demonstrates solid market positioning as a cybersecurity giant with substantial scale and established infrastructure. The company's second-quarter results showed revenue growth of 14% year over year to $1.63 billion, with billings increasing 15% to $1.78 billion. Its comprehensive Security Fabric platform and leadership position in network firewalls provide a stable foundation for consistent revenue generation. The company's recent innovations in quantum-safe security and expanded FortiAI capabilities position it to address emerging threats, though implementation timelines remain company faces notable challenges in maintaining growth momentum. Following its latest earnings announcement, Fortinet's stock dropped 17% in after-hours trading despite beating earnings estimates, reflecting investor concerns about future growth rates. The company's guidance for third-quarter revenues of $1.67-$1.73 billion, while above consensus, suggests a moderation in growth trajectory. Additionally, Fortinet's hardware-centric model faces pressure as enterprises increasingly shift toward cloud-native security solutions. Competition from pure-play cloud security vendors and the need for significant R&D investments to maintain technological parity present ongoing operational challenges that could impact margin expansion and profitability in the medium consensus mark for 2025 earnings is pegged at $2.51 per share, indicating 5.91% year-over-year growth. Fortinet, Inc. Price and Consensus Fortinet, Inc. price-consensus-chart | Fortinet, Inc. Quote The Case for QLYS Qualys emerges as a compelling growth story with exceptional momentum in the rapidly expanding cloud security and vulnerability management market. The company's second-quarter performance showcased remarkable resilience with 10% revenue growth to $164.1 million and impressive 82% GAAP gross margins, demonstrating superior operational efficiency. Its groundbreaking launch of the industry's first Agentic AI-powered Risk Operations Center represents a transformative leap in autonomous cybersecurity, positioning Qualys at the forefront of next-generation threat management. The platform's ability to reduce risk exposure by 85% and accelerate remediation by 70% creates substantial value for enterprises struggling with expanding attack company's strategic initiatives are yielding exceptional results, with its TotalAI solution addressing critical AI and LLM security challenges that represent a massive untapped market opportunity. Qualys' achievement of FedRAMP certification opens significant federal market opportunities, while its partnerships with companies like Mulberri for cyber insurance integration create innovative revenue streams. The company's focus on subscription-based recurring revenues provides predictable cash flows, with strong customer retention rates and expanding deal sizes. Management's confidence is evident in their raised 2025 revenue guidance to $656-662 million, representing 8-9% growth, while maintaining industry-leading profitability metrics that position Qualys for sustained consensus mark for 2025 earnings is pegged at $6.35 per share, indicating 3.59% year-over-year growth. Qualys, Inc. Price and Consensus Qualys, Inc. price-consensus-chart | Qualys, Inc. Quote Valuation and Price Performance Comparison Both companies trade at premium valuations reflecting their market positions, though with notable differences. Fortinet currently trades at a P/E ratio of 30.18, significantly below its 10-year historical average of 140, suggesting potential undervaluation despite premium pricing relative to the broader Zacks Security industry average of 92.39. Qualys trades at a more attractive P/E ratio of 19.88, below both its historical average and peer group average of 36.5, indicating better relative value. FTNT vs. QLYS: P/E F12M Ratio Image Source: Zacks Investment Research In terms of price performance, Fortinet's stock has experienced significant volatility, dropping over 25% from its 52-week high following recent earnings, currently down 14.5% year to date. Comparatively, Qualys has shown more stability with a decline of 6.8% year to date. FTNT Underperforms QLYS YTD Image Source: Zacks Investment Research Conclusion While both companies operate in the high-growth cybersecurity sector, Qualys presents a more compelling investment opportunity with its innovative AI-driven platform, superior margins, and attractive valuation. The company's pioneering Agentic AI technology, 82% gross margins and expanding federal opportunities through FedRAMP certification create a favorable risk-reward profile compared with Fortinet. Qualys' focus on autonomous risk management addresses the industry's most pressing challenge — the overwhelming volume of security threats — positioning it for accelerated growth. Investors should consider buying Qualys stock for its exceptional innovation trajectory and operational excellence, while adopting a hold or wait approach for Fortinet until clearer growth catalysts emerge or valuations become more attractive. QLYS currently sports a Zacks Rank #1 (Strong Buy), whereas FTNT has a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks #1 Rank stocks here. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Fortinet, Inc. (FTNT) : Free Stock Analysis Report Qualys, Inc. (QLYS) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
